Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jana Von Hehn"'
Autor:
Pradyumna Byappanahalli Suresha, Heather O’Leary, Daniel C. Tarquinio, Jana Von Hehn, Gari D. Clifford
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Rett syndrome, a rare genetic neurodevelopmental disorder in humans, does not have an effective cure. However, multiple therapies and medications exist to treat symptoms and improve patients’ quality of life. As research continues to discover and e
Externí odkaz:
https://doaj.org/article/4ab9cbf7fa1c4744a75fd9e0fc325025
Autor:
Cary Fu, Dallas Armstrong, Eric Marsh, David Lieberman, Kathleen Motil, Rochelle Witt, Shannon Standridge, Paige Nues, Jane Lane, Tristen Dinkel, Monica Coenraads, Jana von Hehn, Katie Hale, Bernhard Suter, Daniel Glaze, Jeffrey Neul, Alan Percy, Timothy Benke
Publikováno v:
BMJ Paediatrics Open, Vol 4, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/cf674e2501f94e23a3c1e9b1f99a4d48
Publikováno v:
Metabolites, Vol 2, Iss 3, Pp 596-613 (2012)
STX209 is an exploratory drug comprising the single, active R-enantiomer of baclofen which is in later stage clinical trials for the treatment of fragile x syndrome (FXS) and autism spectrum disorders (ASD). New clinical data in this article on the m
Externí odkaz:
https://doaj.org/article/0ea99961978841f1905a8d77cf6536eb
Autor:
Melissa Raspa, Angela Gqaltney, Carla Bann, Jana von Hehn, Timothy A. Benke, Eric D. Marsh, Sarika U. Peters, Amitha Ananth, Alan K. Percy, Jeffrey L. Neul
Purpose: Rett syndrome is a severe neurodevelopmental disorder that affects about 1 in 10,000 females. Clinical trials of disease modifying therapies are on the rise, but there are few psychometrically sound caregiver-reported outcome measures availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ff237ed3f564fe4a6e92d4c945fffe3
https://doi.org/10.21203/rs.3.rs-2873717/v1
https://doi.org/10.21203/rs.3.rs-2873717/v1
Autor:
David N. Lieberman, Monica Coenraads, Shannon M. Standridge, Dallas Armstrong, Jana von Hehn, Kathleen J. Motil, Bernhard Suter, Katie Hale, Cary Fu, Daniel G. Glaze, Paige Nues, Rochelle Witt, Tristen Dinkel, Tim A. Benke, Eric D. Marsh, Jane B. Lane, Alan K. Percy, Mary Jones, Jeffrey L. Neul
Publikováno v:
BMJ Paediatrics Open
BMJ Paediatrics Open, Vol 4, Iss 1 (2020)
BMJ Paediatrics Open, Vol 4, Iss 1 (2020)
BackgroundRett syndrome (RTT) is a severe neurodevelopmental disorder with complex medical comorbidities extending beyond the nervous system requiring the attention of health professionals. There is no peer-reviewed, consensus-based therapeutic guida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e200dd0d605e53418afc88241829637
https://pubmed.ncbi.nlm.nih.gov/32984552
https://pubmed.ncbi.nlm.nih.gov/32984552
Publikováno v:
Metabolites; Volume 2; Issue 3; Pages: 596-613
Metabolites, Vol 2, Iss 3, Pp 596-613 (2012)
Metabolites
Metabolites, Vol 2, Iss 3, Pp 596-613 (2012)
Metabolites
STX209 is an exploratory drug comprising the single, active R-enantiomer of baclofen which is in later stage clinical trials for the treatment of fragile x syndrome (FXS) and autism spectrum disorders (ASD). New clinical data in this article on the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e676b327833c5e77e399f6737c3d7a
https://doi.org/10.3390/metabo2030596
https://doi.org/10.3390/metabo2030596